期刊文献+

非酒精性脂肪肝与肝癌关系的研究进展 被引量:15

原文传递
导出
摘要 非酒精性脂肪性肝病(NAFLD),是一种无过量饮酒史,患者饮用乙醇量介于少量(男性〈140g/周,女性〈70g/周)和过量(男性〉280g/周,女性〉140g/周)之间,主要以肝实质脂肪变性和脂肪贮积为特征的临床病理综合症。根据其发展进程不同,其疾病谱包括非酒精性单纯性脂肪肝(NAFL)、非酒精性脂肪性肝炎(NASH)及其相关肝硬化和肝细胞癌(HCC)[1]。HCC是世界上第五大最常见的恶性肿瘤,在癌症相关死亡中居第二位[2]。
出处 《中华实验和临床病毒学杂志》 CAS CSCD 2014年第2期159-160,F0003,共3页 Chinese Journal of Experimental and Clinical Virology
基金 浙江省医药卫生科技项目(2010KYAl64)
  • 相关文献

参考文献36

  • 1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南(2010年修订版).中华肝脏病杂志,2010,18:163-166.
  • 2Tian Y, Vincent Wong WS, Henry Chan LY, Alfred Cheng SL, Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: Which clinical arguments? Seminars in Cancer Biology 23P (2013 ) 471-452.
  • 3Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosisto hepatocellular carcinoma. Gastroenterology, 2002 ; 123 ( 1 ) : 134-140.
  • 4Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatoeellular carcinoma in patients with non-alcoholic steatohepatitis. Hepatology 2010; 51 : 1972-1978.
  • 5Rosmordue O. Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: Which clinical arguments? Annales d "endocfinologie, 2013 ; 74 ( 2 ) : 115-120.
  • 6MeCullough AJ. Natural history of nonalcoholic steatohepatitis. In: Arroyo V, Forns X, Garcia-Pag6n JC et al, eds. Progress in the Treatment of Liver Disease. Barcelona: Medicina STM Editores 2003 : 219-225.
  • 7Ertle J, Dechene A, Sowa JP, et al. Nonalcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis, lnt J Cancer. 2011 ; 128:2436-2443.
  • 8Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetesin patients with cryptogenic cirrhosis: a case-control study. Hepatology2000 ; 32 : 689-692.
  • 9Caldwell SH, Oelsner DH, Iezzoni J et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999 ; 29 : 664-669.
  • 10Ong JP, Younossi ZM. Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis? Gastroenterology. 2002; 123: 375-378.

二级参考文献21

  • 1程朝英,卢仙娥,钟朝晖,廖蓉,付冀平,赵织天,徐渝,蒋在强,严立,涂珍碧,王莎,雷鹰,王凯,王艺,喻德洲,陈文,唐兴权,廖惠,鞠朝林,敖平.重庆市不同职业人群中脂肪肝现况调查与分析[J].重庆医学,2005,34(12):1807-1809. 被引量:30
  • 2中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].药品评价,2007,4(2):77-79. 被引量:42
  • 3Berg AH,Combs TP,Du X,et al.The adiocyte-secereted protein Acrp 30 enhances hepatic insulin action.Nat Med,2001,7:947-953.
  • 4Combs TP,Pajvani UB,Berg AH,et al.A transgenic mouse with a deletion in the collagenous doin of adiponectin displays elebated circulating adiponectin and improvde insulin sensitivity.Endocrinology,2004,125:367-383.
  • 5Yamamoto Y,Hirose H,Saito I,et al.Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol,independent of body mass index,in the Japanese population.Clin Sci(Lond),2002,103:137-142.
  • 6Das K,Lin Y,Widen E,et al.Chromesomal localization,expression pattern,and promoter analysis of the mouse gene encoding adipocyte-specific secretory protein Acrp30.Biochem Biophys Res Commun,2001,280(4):1120-9.
  • 7Brunt EM.Nonalcoholic steatohepatitis.Semin Liver Dis,2004,24:3-20.
  • 8Viengchareun S,Zennaro MC,Pascual-Le Tallec L,et al.Brown adipocytes are novel sites of expression and regulation of adiponectin and resistin.FEBS Lett,2002,532:345-350.
  • 9Arun JS.AGA technical review on nonalcoholic fatty liver disease.Gastroenterology,2002,123:1705-1725.
  • 10Kawanami D,Maemura K,Takeda N,et al.Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells:a new insight into adipocytokine-endothelial cell interactians.Biochem Biophys Res Commun,2004,314:415-419.

共引文献8

同被引文献111

引证文献15

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部